Advertisement

The Use of Biochemical Parameters to Evaluate and to Estimate the Nutritional Status of Kidney Patients

  • J. Bergström

Abstract

Uremia is a toxic syndrome caused by severe glomerular insufficiency, associated with disturbances in tubular and endocrine functions of the kidneys. It is characterized by retention of toxic metabolites, derived mainly from protein metabolism, associated with changes in volume and electrolyte composition of the body fluids and excess or deficiency of various hormones.

Keywords

Plasma Amino Acid Uremic Patient Protein Malnutrition Amino Acid Pattern Intracellular Amino Acid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Diamond JR, Yoburn DC. Nonoliguric acute renal failure. Arch Intern Med 1982; 142: 1882–1884.CrossRefGoogle Scholar
  2. 2.
    Bergström J, Fürst P. Uraemic toxins. In: Drukker W, Parsons FM, Maher JF, eds. Replacement of renal function by dialysis. The Hague: Martinus Nijhoff’s Publishers, 1983: 354–390.Google Scholar
  3. 3.
    DeFronzo RA, Alvestrand A, Smith D, Hendler R, Hendler E, Wahren J. Insulin resistance in uremia. J Clin Invest 1981; 67: 563–568.CrossRefGoogle Scholar
  4. 4.
    Norbeck HE, Carlson L. The uremic dyslipoproteinemia: Its characteristics and relations to clinical factors. Acta Med Scand 1981; 289: 489–504.Google Scholar
  5. 5.
    Attman PO. Dietary treatment in uremia. Renal function, protein and lipid metabolism. Thesis. Näringsforskning 1979; 23: 40–59.Google Scholar
  6. 6.
    Bergström J. Discovery and rediscovery of low protein diet. Clin Nephrol 1984; 21: 29–35.Google Scholar
  7. 7.
    Grodstein GP, Blumenkrantz MJ, Kopple JD. Nutritional and metabolic response to catabolic stress in uremia. Am J Clin Nutr 1980; 33: 1411–1416.Google Scholar
  8. 8.
    Feinstein EI, Blumenkrantz MJ, Healy M, et al. Clinical and metabolic responses to parenteral nutrition in acute renal failure. Medicine 1981; 60: 124–137.CrossRefGoogle Scholar
  9. 9.
    Mault JR, Bartlett RH, Dechert RE, Clark SF, Swartz RD. Starvation. A major contribution to mortality in acute renal failure? Trans Am Soc Artif Internal Organs 1983; 29: 390–395.Google Scholar
  10. 10.
    Wolfson M, Jones MR, Kopple JD. Amino acid losses during hemodialysis with infusion of amino acids and glucose. Kidney Int 1982; 21: 500–506.CrossRefGoogle Scholar
  11. 11.
    Bergström J, Alvestrand A, Gutierrez A. Acute and chronic metabolic effects of hemodialysis. In: Smeby LC, Jörstad S, Wideröe TE, eds. Immune and metabolic aspects of therapeutic blood purification systems. Basel: S Karger, 1986: 254–273.Google Scholar
  12. 12.
    Bergström J. Protein catabolic factors in patients on renal replacement therapy. Blood Purif 1985; 3: 215–236.CrossRefGoogle Scholar
  13. 13.
    Gulyassy PF, Aviram A, Peters JH. Evaluation of amino acid and protein requirements in chronic uremia. Arch Intern Med 1970; 126: 855–859.CrossRefGoogle Scholar
  14. 14.
    Young GA, Parsons FM. Plasma amino acid imbalance in patients with chronic failure on intermittent dialysis. Clin Chim Acta 1970; 27: 491–496.CrossRefGoogle Scholar
  15. 15.
    Alvestrand A, Bergström J, Fürst P. Plasma and muscle free amino acids in uremia: influence of nutrition with amino acids. Clin Nephrol 1982; 18: 297–305.Google Scholar
  16. 16.
    Alvestrand A, Fürst P, Bergström J. Intracellular amino acids in uremias. Kidney Int 24 1983; Suppl 16: S9–16.Google Scholar
  17. 17.
    Lindholm B, Alvestrand A, Bergström J. Muscle free amino acids in patients treated with CAPD. In: Maher JF, Winchester JF, eds. Frontiers in peritoneal dialysis. New York: Field, Rich and Assoc Inc., 1986: 400–404.Google Scholar
  18. 18.
    Young GA, Parsons FM. Impairment of phenylalanine hydroxylation in chronic renal insufficiency. Clin Sci Mol Med 1973; 48: 89–97.Google Scholar
  19. 19.
    Bergström J, Qureshi GA, Rashed Qureshi A. Inhibition of cysteine sulphinic acid decarboxylase (CSD) as a cause of taurine (TAU) depletion in uremia. Abstract. Berlin: XXIVth Congr European Dialysis and Transplant Assoc, October 1987.Google Scholar
  20. 20.
    Acchiardo SR, Moore LW, Latour PA. Malnutrition as the main factor in morbidity and mortality of hemodialysis patients. Kidney Int 24, 1983; Suppl 16: S199–203.Google Scholar
  21. 21.
    Blumenkrantz MJ, Kopple JD, Gutman RA, et al. Methods for assessing nutritional status of patients with renal failure. Am J Clin Nutr 1980; 33: 1567–1585.Google Scholar
  22. 22.
    Guarnieri G, Toigo G, Situlin R, et al. Muscle biopsy studies in chronically uremic patients: Evidence for malnutrition. Kidney Int 24, 1983; Suppl 16: S187–193.Google Scholar
  23. 23.
    Borah MF, Schoenfeld PY, Gotch FA, Sargent JA, Wolfson M, Humphreys MH. Nitrogen balance during intermittent dialysis therapy of uremia. Kidney Int 1978; 14: 491–500.CrossRefGoogle Scholar
  24. 24.
    Young GA, Swanepoel CR, Croft MR, Hobson SM, Parsons FM. Anthropometry and plasma valine, amino acids, and proteins in the nutritional assessment of hemodialysis patients. Kidney Int 1982; 21: 492–499.CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1989

Authors and Affiliations

  • J. Bergström
    • 1
  1. 1.Department of Renal Medicine, Karolinska InstituteHuddinge University HospitalStockholmSweden

Personalised recommendations